Skip to main content
. 2013 Nov 11;27(6):494–503. doi: 10.1002/jcla.21633

Table 4.

Comparisons of the Biomarkers in the Subjects With Different Combined Genotypes of MnSOD1183T>C and MPO‐463G>A

Heavy drinkers Nonheavy drinkers
MnSOD TT MnSOD TC + CC MnSOD TT MnSOD TC + CC
MPO MPO MPO MPO MPO MPO MPO MPO
GG [A] GA + AA [B] GG [C] GA + AA [D] GG [A] GA + AA [B] GG [C] GA + AA [D]
Parameters (n = 45) (n = 43) (n = 10) (n = 10) (n = 50) (n = 23) (n = 21) (n = 12)
Immunological tests
CD3+ cells (%) 65.7 ± 11.0 65.9 ± 7.9 65.3 ± 8.4 67.3 ± 8.9 63.2 ± 7.3 62.3 ± 9.4 66.4 ± 9.1 64.2 ± 10.9
CD4+ cells (%) 35.7 ± 9.6 37.2 ± 9.0 30.3 ± 5.7 38.3 ± 8.8 32.4 ± 8.1 33.0 ± 7.6 28.4 ± 7.9 33.8 ± 8.7
CD8+ cells (%) 23.0 ± 7.0 22.5 ± 6.8 21.7 ± 5.0 20.7 ± 5.7 23.6 ± 6.0 23.1 ± 5.1 27.0 ± 8.8 25.5 ± 6.0
CD19+ cells (%) 10.5 ± 3.7 11.1 ± 4.6 10.5 ± 3.8 16.0 ± 3.4a , b , c 12.2 ± 4.8 12.8 ± 3.9 11.9 ± 4.6 9.8 ± 4.2
IgG (mg/dl) 1118 ± 200 1134 ± 255 1195 ± 293 1071 ± 253 1194 ± 248 1243 ± 322 1234 ± 213 1232 ± 191
IgM (mg/dl) 82 ± 37 98 ± 52 92 ± 44 84 ± 35 95 ± 40 111 ± 45 156 ± 73a , b , d 90 ± 45
IL‐2R (U/l) 359 ± 118 371 ± 140 382 ± 188 443 ± 145 361 ± 167 392 ± 138 338 ± 120 357 ± 100
IL‐6 (ng/ml) 3.9 ± 2.0 3.8 ± 2.1 3.4 ± 1.1 5.8 ± 1.9a , b , c 3.4 ± 2.2 3.6 ± 2.0 2.9 ± 1.6 2.9 ± 1.4
IL‐8 (ng/ml) 9.8 ± 4.7 11.0 ± 5.1 8.6 ± 2.8 11.9 ± 6.5 9.2 ± 5.2 9.7 ± 7.3 8.8 ± 7.0 8.9 ± 3.3
IL‐10 (ng/ml) 2.0 ± 1.1 1.9 ± 1.0 2.3 ± 1.1 1.8 ± 0.4 1.8 ± 1.3 2.1 ± 1.2 1.3 ± 0.7 1.8 ± 1.4
TNF‐α (pg/ml) 10.9 ± 9.8 9.5 ± 6.6 6.8 ± 1.8 8.2 ± 2.6 10.0 ± 9.1 11.7 ± 9.0 11.3 ± 11.0 8.1 ± 2.8

The alphabet in the square bracket indicates the group of the study.

a

P <0.05, compared with Group A in the heavy drinkers or nonheavy drinkers, respectively.

b

P <0.05, compared with Group B in the heavy drinkers or nonheavy drinkers, respectively.

c

P <0.05, compared with Group C in the heavy drinkers.

d

P <0.05, compared with Group D in the nonheavy drinkers.

CD, cluster differentiation; Ig, immunoglobulin; IL, interleukin; TNF, tumor necrosis factor.